Prevalence of Hepatitis B and C Markers in the South-east of Spain: An Unlinked Community-based Serosurvey of 2,203 Adults

References

• Esteban JI, Esteban R, Viladomiu L, López Talavera JC, Gonzalez A, Hernández JM, Roget M, Vargas V, Genescá J, Buti M, Guardia J. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–296
   PubMed Web of Science ®Google Scholar
• Suárez A, Riestra S, Rodriguez M, Linares A, Otero L, Rodrigo L. Análisis comparativo de donantes de sangre con anticuerpos frente a los virus C de la hepatitis, positividad para el antigeno de superficie de la hepatitis B y con hipertransami-nasemia en Asturias. Med Clin (Barc) 1994; 103: 209–213
   PubMedGoogle Scholar
• Salleras L, Bruguera M, Vidal J, Plans P, Dominguez A, Navas E, Espunes J, Taberner JL, Jimencz de Anta MT, Rodés J. Seroepidemiologia de la infeccion por el virus de la hepatitis C en las mujeres embarazadas en Cataluña. Med Clin (Barc) 1994; 103: 721–724
   PubMedGoogle Scholar
• Garcia Bengoechea M, Sarriugarte A, Emparanza JI, Cortés A, Vega JL, Gonzalez F, Arenas JI. La infección por el virus de la hepatitis C (VHC) en la población general. Seroprevalencia y factores de riesgo [abstract]. Gastroenterol Hepatol 1993; 16: 263–264
   Google Scholar
• Salleras L, Bruguera M, Vidal J, Taberner JL, Plans P, Bayas JM, Pumarola T, Jimenez de Anta MT, Rodes J. Prevalence of hepatitis B markers in the population of Catalonia (Spain) Rationale for universal vaccination of adolescents. Eur J Epidemiol 1992; 8: 640–4
   PubMedGoogle Scholar
• Documenta Geigy. Tablas Cientificas, 7th edn., K Diem, C Lentner. Ciba-Geigy, Barcelona 1975; 189
   Google Scholar
• Tormo MJ, Navarro C, Chirlaque D, Pérez-Flores D, Moreno-Sueskun I. Factores de riesgo cardiovascular en la Región de Murcia, 1992. Serie Informes No. 20, Consejeria de Sanidad y Asuntos Sociales, Murcia 1995
   Google Scholar
• Winn DM, Reichman ME, Gunter E. Epidemiologic issues in the design and use of biologic specimen banks. Epidemiol Rev 1990; 12: 56–70
   PubMedGoogle Scholar
• Global Programme on AIDS, World Health Organization. Unlinked anonymous creening for the public health surveillance of HIV infections. Proposed international guidelines. WHO document GPA/SFI/89.3, Geneva 1989
   Google Scholar
• Levy PS, Lemeshow S. Sampling for health professionals. Lifetime Learning Publications, Belmont, CAUSA 1980; 106–134
   Google Scholar
• Forthofer RN. Investigation of nonresponse bias in NHANES II. Am J Epidemiol 1983; 117: 507–515
   PubMed Web of Science ®Google Scholar
• Liberatos P, Link BG, Kelsey JL. The measurement of social class in epidemiology. Epidemiol Rev 1988; 10: 87–121
   PubMed Web of Science ®Google Scholar
• D'Amelio R, Matricardi PM, Biselli R, Stroffolini T, Mele A, Spada E, Chionne P, Rapicetta M, Ferrigno L, Pasquini P. Changing epidemiology of hepatitis B in Italy: Public health implications. Am J Epidemiol 1992; 135: 1012–1018
   PubMed Web of Science ®Google Scholar
• World Health Organization. Viral hepatitis. Bull WHO 1982; 60: 661–691
   PubMedGoogle Scholar
• Lecour H, Ribeiro AT, Amaral I, Rodrigues MA. Prevalence of viral hepatitis markers in the population of Portugal. Bull WHO 1984; 62: 743–747
   PubMed Web of Science ®Google Scholar
• Puro V, Girardi E, Ippolito G, Lo Presti E, Benedetto A, Zaniratti S, Giannini V, Gioia C, Natili S, Tossini G, Pomini P, Rizzi N, Tellini P. Prevalence of hepatitis B and C viruses and human immunedeficiency virus infections in women of reproductive age. Br J Obst Gynaecol 1992; 99: 598–600
   PubMedGoogle Scholar
• Struve J, Giesecke J, Olcen P, Von Sydow M, Weiland O. Prevalence of hepatitis B virus markers in Sweden: a community-based serosurvey of 4000 young swedish adults. Am J Epidemiol 1992; 135: 409–17
   PubMedGoogle Scholar
• Shapiro CN, Margolis HS. Hepatitis B Epidemiology and Prevention. Epidemiolog Rev 1990; 12: 221–227
   PubMed Web of Science ®Google Scholar
• Sirchia G, Almini D, Bellobuono A, Giovanetti AM, Marconi M, Mercuriali F, Mozzi F, Parravicini A, Pizzi M, Zanuso F. and the Italian Cooperative Group. Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sang 1990; 59: 26–29
   PubMedGoogle Scholar
• Ranger S, Martin P, Roussanne MC, Denis F. Prevalence of hepatitis C virus antibodies in the general population and in selccted groups of patients in Limoges France. Gut 1993; 34: S50–S51, Suppl
   Google Scholar
• Chaudhary RK, Mo T. Antibody to hepatitis C virus in risk groups in Canada. Can Dis Wkly Rep 1990; 16: 23–25
   PubMedGoogle Scholar
• Patiño-Sarcinelli F, Hyman J, Camacho L AB, Linhares DB, Azevedo JG. Prevalence and risk factors for hepatitis C antibodies in volunteer blood donors in Brazil. Transfusion 1994; 34: 138–141
   PubMedGoogle Scholar
• Roudet-Thoraval F, Pawlotsky JM, Deforges L, Girollet PP, Dhumeaux D. Anti-HCV seroprevalence in pregnant women in France. Gut 1993; 34: S55–S56, Suppl
   Google Scholar
• Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K, Furuta S. Watanabe Y, Watanabe J, Fukuda Y, Takayama T, and the South Kiso Hepatitis Study Group. Tranmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 1994; 106: 1596–1602
   PubMed Web of Science ®Google Scholar
• Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 1475–1479
   PubMed Web of Science ®Google Scholar
• Alter MJ. Review of serological testing for hepatitis C virus infection and risk of posttransfusion hepatitis C. Arch Pathol Lab Med 1994; 118: 342–345
   PubMedGoogle Scholar